Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now [Yahoo! Finance]
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at UBS Group AG to a "hold" rating.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $7.00 to $6.00. They now have a "sector outperform" rating on the stock.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.